Overview

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to examine how AZD6140 affects patients with severe kidney disease compared to volunteers with normal kidneys. Subjects in the study will receive one dose of AZD6140.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ticagrelor